MRPS28 and glioblastoma: Furthermore, some evidence suggests that several genes expressing MRPs including bS1m (MRPS28), uS2m (MRPS2), uL23m (MRPL23), uS12m (MRPS12), bL12m (MRPL12) and mS34 (MRPS34) may be potential biomarkers for the treatment of glioblastoma with Benzyl isothiocyanate (BITC) [102].